The AIDS Beacon: "Results of a new study suggest that people with HIV who begin antiretroviral therapy soon after infection may better retain the ability to fight off other infectious diseases than people who begin treatment later.
“Our work…suggest[s] that more clinical trials should be aimed at comparing early-treated and chronic-treated patients by a variety of different immunologic parameters,” said Dr. Susan Moir, lead author of the study, in correspondence with The AIDS Beacon.
"The findings shed light on a group of immune cells called B cells and how early initiation of antiretroviral therapy (ART) may help prevent irreversible damage to the immune system."
0 comments:
Post a Comment